Absence of germline and somatic p53 alterations in children with sporadic brain tumors

Journal of Neuro-Oncology

Volumn 52, Issue 3, 2001, Pages 227-235

  Portwine, Carol ^a   Chilton MacNeill, Susan ^a   Brown, Catherine ^b   Sexsmith, Elizabeth ^a   McLaughlin, John ^b   Malkin, David ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Germline; Li fraumeni syndrome; p53; Pediatric; Polymorphism; Sporadic

Indexed keywords

DNA;

ARTICLE; BLOOD; BRAIN TUMOR; CEREBELLUM TUMOR; CHILD; CODON; COMPARATIVE STUDY; GENETICS; GENOTYPE; GLIOMA; HETEROZYGOSITY LOSS; HUMAN; INFANT; MEDULLOBLASTOMA; MUTATION; NEUROECTODERM TUMOR; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROSPECTIVE STUDY; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

BRAIN NEOPLASMS; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; CODON; DNA; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GANGLIOGLIOMA; GENES, P53; GENOTYPE; GERM-LINE MUTATION; GLIOMA; HUMANS; INFANT; LOSS OF HETEROZYGOSITY; MEDULLOBLASTOMA; NEUROECTODERMAL TUMORS, PRIMITIVE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROSPECTIVE STUDIES;

EID: 0035347120     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010661831335     Document Type: Article

References (57)

1. Pizzo P, Poplak D, (eds): Principles and Practice of Pediatric Oncology. 3rd edn., Lippincott-Raven, Philadelphia, 1997
2. Li FP, Fraumeni JF Jr: Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med 71(4): 747-752, 1969
3. Li FP, Fraumeni JF Jr: Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst 43(6): 1365-1373, 1969
4. Garber JE, Goldstein AM, Kantor AF, Dreyfus MG, Fraumeni JF Jr, Li FP: Follow-up study of twenty-four families with Li-Fraumeni syndrome. Cancer Res 51(22): 6094-6097, 1991
5. Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff JZ, Tainsky MA, Friend SH: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms (see comments). Science 250(4985): 1233-1238, 1990
6. Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH: Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome (see comments). Nature 348(6303): 747-749, 1990
7. Frebourg T, Kassel J, Lam KT, Gryka MA, Barbier N, Andersen TI, Borresen AL, Friend SH: Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein. Proc Natl Acad Sci USA 89(14): 6413-6417, 1992
8. Varley JM, McGown G, Thorncroft M, Santibanez-Koref MF, Kelsey AM, Tricker KJ, Evans DG, Birch JM: Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res 57(15): 3245-3252, 1997
9. Kleihues P, Schauble B, zur Hausen A, Esteve J, Ohgaki H: Tumors associated with p53 germline mutations: a synopsis of 91 families. Am J Pathol 150(1): 1-13, 1997
10. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R, Harris CC: Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 22(17): 3551-3555, 1994
11. McBride OW, Merry D, Givol D: The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13). Proc Natl Acad Sci USA 83(1): 130-134, 1986
12. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 88(3): 323-331, 1997
13. Chen P, lavarone A, Fick J, Edwards M, Prados M, Israel MA: Constitutional p53 mutations associated with brain tumors in young adults. Cancer Genet Cytogenet 82(2): 106-115, 1995
14. Felix CA, Slave I, Dunn M, Strauss EA, Phillips PC, Rorke LB, Sutton L, Bunin GR, Biegel JA: p53 gene mutations in pediatric brain tumors. Med Pediatr Oncol 25(6): 431-436, 1995
15. Orellana C, Hernandez-Marti M, Martinez F, Castel V, Millan JM, Alvarez-Garijo JA, Prieto F, Badia L: Pediatric brain tumors: loss of heterozygosity at 17p and TP53 gene mutations. Cancer Genet Cytogenet 102(2): 93-99, 1998
16. Phelan CM, Liu L, Ruttledge MH, Muntzning K, Ridderheim PA, Collins VP: Chromosome 17 abnormalities and lack of TP53 mutations in paediatric central nervous system tumours. Hum Genet 96(6): 684-690, 1995
17. Biegel JA, Burk CD, Barr FG, Emanuel BS: Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Res 52(12): 3391-3395, 1992
18. Bhattacharjee MB, Bruner JM: p53 protein in pediatric malignant astrocytomas: a study of 21 patients. J Neuro-Oncol 32(3): 225-233, 1997
19. Kyritsis AP, Bondy ML, Xiao M, Berman EL, Cunningham JE, Lee PS, Levin VA, Saya H: Germline p53 gene mutations in subsets of glioma patients (see comments). J Natl Cancer Inst 86(5): 344-349, 1994
20. Li YJ, Sanson M, Hoang-Xuan K, Delattre JY, Poisson M, Thomas G, Hamelin R: Incidence of germ-line p53 mutations in patients with gliomas. Int J Cancer 64(6): 383-387, 1995
21. Wagner J, Portwine C, Rabin K, Leclerc JM, Narod SA, Malkin D: High frequency of germline p53 mutations in childhood adrenocortical cancer. J Natl Cancer Inst 86(22): 1707-1710, 1994
22. Varley JM, McGown G, Thorncroft M, James LA, Margison GP, Forster G, Evans DG, Harris M, Kelsey AM, Birch JM: Are there low-penetrance TP53 alleles? evidence from childhood adrenocortical tumors. Am J Hum Genet 65(4): 995-1006, 1999
23. McIntyre JF, Smith-Sorensen B, Friend SH, Kassell J, Borresen AL, Yan YX, Russo C, Sato J, Barbier N, Miser J, Malkin D, Gebhardt MC: Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J Clin Oncol 12(5): 925-930, 1994
24. Diller L, Sexsmith E, Gottlieb A, Li FP, Malkin D: Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma. J Clin Invest 95(4): 1606-1611, 1995
25. Felix CA, Nau MM, Takahashi T, Mitsudomi T, Chiba I, Poplack DG, Reaman GH, Cole DE, Letterio JJ, Whang-Peng J, Knutsen T, Minna JD: Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia. J Clin Invest 89(2): 640-647, 1992
26. Borresen AL, Andersen TI, Garber J, Barbier-Piraux N, Thorlacius S, Eyfjord J, Ottestad L, Smith-Sorensen B, Hovig E, Malkin D, Friend SH: Screening for germ line TP53 mutations in breast cancer patients. Cancer Res 52(11): 3234-3236, 1992
27. Sidransky D, Tokino T, Helzlsouer K, Zehnbauer B, Rausch G, Shelton B, Prestigiacomo L, Vogelstein B, Davidson N: Inherited p53 gene mutations in breast cancer. Cancer Res 52(10): 2984-2986, 1992
28. Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J, Crawford LV: Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 7(2): 961-963, 1987
29. Beckman G, Birgander R, Sjalander A, Saha N, Holmberg PA, Kivela A, Beckman L: Is p53 polymorphism maintained by natural selection? Hum Hered 44(5): 266-270, 1994
30. Sjalander A, Birgander R, Saha N, Beckman L, Beckman G: p53 polymorphisms and haplotypes show distinct differences between major ethnic groups. Hum Hered 46(1): 41-48, 1996
31. Walker KK, Levine AJ: Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci USA 93(26): 15,335-15,340, 1996
32. Sakamuro D, Sabbatini P, White E, Prendergast GC: The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 15(8): 887-898, 1997
33. Zhu J, Jiang J, Zhou W, Zhu K, Chen X: Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity. Oncogene 18(12): 2149-2155, 1999
34. Mashiyama S, Murakami Y, Yoshimoto T, Sekiya T, Hayashi K: Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 6(8): 1313-1318, 1991
35. Peng HQ, Hogg D, Malkin D, Bailey D, Gallie BL, Bulbul M, Jewett M, Buchanan J, Goss PE: Mutations of the p53 gene do not occur in testis cancer. Cancer Res 53(15): 3574-3578, 1993
36. Harris N, Brill E, Shohat O, Prokocimer M, Wolf D, Arai N, Rotter V: Molecular basis for heterogeneity of the human p53 protein. Mol Cell Biol 6(12): 4650-4656, 1986
37. STATA-Statistics/Data Analysis (version 6), College Station, Texas: Stata Corporation, 1999
38. Carbone D, Chiba I, Mitsudomi T: Polymorphism at codon 213 within the p53 gene. Oncogene 6(9): 1691-1692, 1991
39. Bhatia K, Gutierrez MI, Huppi K, Magrath IT: PCR detection of a neutral CGA/CGC dimorphism in exon 6 of the human p53 gene. Nucleic Acids Res 20(4): 928, 1992
40. Felley-Bosco E, Weston A, Cawley HM, Bennett WP, Harris CC: Functional studies of a germ-line polymorphism at codon 47 within the p53 gene. Am J Hum Genet 53(3): 752-759, 1993
41. Varley JM, Thorncroft M, McGown G, Appleby J, Kelsey AM, Tricker KJ, Evans DG, Birch JM: A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene. Oncogene 14(7): 865-871, 1997
42. Mousses S, Ozcelik H, Lee PD, Malkin D, Bull SB, Andrulis IL: Two variants of the CIP1/WAF1 gene occur together and are associated with human cancer. Hum Mol Genet 4(6): 1089-1092, 1995
43. Avigad S, Barel D, Blau O, Malka A, Zoldan M, Mor C, Fogel M, Cohen IJ, Stark B, Goshen Y, Stein J, Zaizov R: A novel germline p53 mutation in intron 6 in diverse childhood malignancies. Oncogene 14(13): 1541-1545, 1997
44. Lehman TA, Haffty BG, Carbone CJ, Bishop LR, Gumbs AA, Krishnan S, Shields PG, Modali R, Turner BC: Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer. Cancer Res 60(4): 1062-1069, 2000
45. Olschwang S, Laurent-Puig P, Vassal A, Salmon RJ, Thomas G: Characterization of a frequent polymorphism in the coding sequence of the Tp53 gene in colonie cancer patients and a control population. Hum Genet 86(4): 369-370, 1991
46. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G: Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19(2): 1092-1100, 1999
47. Kawajiri K, Nakachi K, Imai K, Watanabe J, Hayashi S: Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis 14(6): 1085-1089, 1993
48. Jin X, Wu X, Roth JA, Amos CI, King TM, Branch C, Honn SE, Spitz MR: Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis 16(9): 2205-2208, 1995
49. Sjalander A, Birgander R, Hallmans G, Cajander S, Lenner P, Athlin L, Beckman G, Beckman L: p53 polymorphisms and haplotypes in breast cancer. Carcinogenesis 17(6): 1313-1316, 1996
50. Murata M, Tagawa M, Kimura H, Kakisawa K, Shirasawa H, Fujisawa T: Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small cell lung cancer patients. Int J Oncol 12(3): 577-581, 1998
51. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L: Role of a p53 polymorphism in the development of human papillomavirus-associated cancer (see comments). Nature 393(6682): 229-234, 1998
52. Tagawa M, Murata M, Kimura H: Prognostic value of mutations and a germ line polymorphism of the p53 gene in non-small cell lung carcinoma: association with clinicopathological features. Cancer Lett 128(1): 93-99, 1998
53. Wang YC, Lee HS, Chen SK, Chang YY, Chen CY: Prognostic significance of p53 codon 72 polymorphism in lung carcinomas (In Process Citation). Eur J Cancer 35(2): 226-230, 1999
54. Birgander R, Sjalander A, Rannug A, Alexandrie AK, Sundberg MI, Seidegard J, Tornling G, Beckman G, Beckman L: P53 polymorphisms and haplotypes in lung cancer. Carcinogenesis 16(9): 2233-2236, 1995
55. Sjalander A, Birgander R, Athlin L, Stenling R, Rutegard J, Beckman L, Beckman G: P53 germ line haplotypes associated with increased risk for colorectal cancer. Carcinogenesis 16(7): 1461-1464, 1995
56. Rosenthal AN, Ryan A, Al-Jehani RM, Storey A, Harwood CA, Jacobs IJ: p53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet 352(9131): 871-872, 1998
57. Wang-Gohrke S, Rebbeck TR, Besenfelder W, Kreienberg R, Runnebaum IB: p53 germline polymorphisms are associated with an increased risk for breast cancer in German women. Anticancer Res 18(3B): 2095-2099, 1998